Genius Sports vs Madison Square Garden Sports
GENI and MSGS side by side, both in miscellaneous amusement and recreation. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How GENI and MSGS compare
Genius Sports grew revenue faster over the last twelve months (31.0% versus 11.0% for Madison Square Garden Sports).
Madison Square Garden Sports keeps more of each dollar of sales as profit, with a net margin of 0.67% compared with −16.7% at Genius Sports.
Madison Square Garden Sports pays a dividend yielding 1.8%; Genius Sports does not pay one.
Genius Sports scores higher on the StockData Score (8 against 6 for Madison Square Garden Sports), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | GENI | MSGS |
|---|---|---|
| Size and price | ||
| Market cap | – | $9.4B |
| Share price | $6.36 | $388.63 |
| Change, 1 year | −45.8% | 72.3% |
| Change, 5 years | −64.6% | 105% |
| Beta (5Y) | 1.55 | 0.61 |
| Employees | 2,700 | 522 |
| StockData Score | ||
| Total score | 8 (better) | 6 |
| Valuation score | 0 | 0 |
| Growth score | 2 (better) | 1 |
| Performance score | 1 (better) | 0 |
| Health score | 5 (better) | 2 |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | – | 1214× |
| P/S | – | 8.1× |
| EV/EBITDA | – | 295× |
| P/FCF | – | 153× |
| FCF yield | – | 0.65% |
| Fair value | – | $27.32 |
| Margin of safety | – | −1323% |
| Growth | ||
| Revenue growth (TTM) | 31.0% (better) | 11.0% |
| Revenue growth, 5Y average | 34.9% (better) | 22.6% |
| Profitability | ||
| Gross margin | 23.0% | – |
| Operating margin | −22.6% | 2.5% (better) |
| Net margin | −16.7% | 0.67% (better) |
| FCF margin | 9.6% (better) | 5.3% |
| Return on equity | −17.2% | – |
| Return on invested capital | −26.4% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Net debt / EBITDA | – | 2.93 |
| Interest coverage | – | 1.4× |
| Current ratio | 1.56 (better) | 0.50 |
| Altman Z-score | – | 3.56 |
| Piotroski F-score | 5 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 1.8% |
| Payout ratio | – | 6.1% |
| Years of dividend growth | – | 0 |
| Shareholder yield | – | 1.8% |
| Ownership | ||
| Held by institutions | – | 76.6% |
| Held by insiders | – | 41.2% |
| Insider net buying, 12 months | −$5.6M | −$2.1M (better) |
| Superinvestors holding | 2 | 3 (better) |
| Short interest, % of float | – | 11.9% |
Go deeper
- GENI stock overview
- GENI income statement
- GENI valuation and score
- MSGS stock overview
- MSGS income statement
- MSGS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.